Rachana D Shah1, Zheng-Zheng Tang2, Guanhua Chen2, Shi Huang3, Jane F Ferguson4. 1. Division of Pediatric Endocrinology, Children's Hospital of Philadelphia, PA, USA. 2. Department of Biostatistics and Medical Informatics, University of Wisconsin-Madison, Madison, WI, USA; Wisconsin Institute for Discovery, Madison, WI, USA. 3. Department of Biostatistics, Vanderbilt University, Nashville, TN, USA; Vanderbilt Translational and Clinical Cardiovascular Research Center (VTRACC), Vanderbilt University Medical Center, Nashville, TN, USA. 4. Vanderbilt Translational and Clinical Cardiovascular Research Center (VTRACC), Vanderbilt University Medical Center, Nashville, TN, USA; Division of Cardiovascular Medicine, Vanderbilt University Medical Center, Nashville, TN, USA. Electronic address: jane.f.ferguson@vumc.org.
Abstract
BACKGROUND AND AIMS: Consumption of soy foods has been associated with protection against cardiometabolic disease, but the mechanisms are incompletely understood. We hypothesized that habitual soy food consumption associates with gut microbiome composition, metabolite production, and the interaction between diet, microbiota and metabolites. METHODS AND RESULTS: We analyzed dietary soy intake, plasma and stool metabolites, and gut microbiome data from two independent cross-sectional samples of healthy US individuals (N = 75 lean or overweight, and N = 29 obese). Habitual soy intake associated with several circulating metabolites. There was a significant interaction between soy intake and gut microbiome composition, as defined by gut enterotype, on metabolites in plasma and stool. Soy consumption associated with reduced systolic blood pressure, but only in a subset of individuals defined by their gut microbiome enterotype, suggesting that responsiveness to soy may be dependent on microbiome composition. Soy intake was associated with differences in specific microbial taxa, including two taxa mapping to genus Dialister and Prevotella which appeared to be suppressed by high soy intake We identified context-dependent effects of these taxa, where presence of Prevotella was associated with higher blood pressure and a worse cardiometabolic profile, but only in the absence of Dialister. CONCLUSIONS: The gut microbiome is an important intermediate in the interplay between dietary soy intake and systemic metabolism. Consumption of soy foods may shape the microbiome by suppressing specific taxa, and may protect against hypertension only in individuals with soy-responsive microbiota. CLINICAL TRIALS REGISTRY: NCT02010359 at clinicaltrials.gov.
BACKGROUND AND AIMS: Consumption of soy foods has been associated with protection against cardiometabolic disease, but the mechanisms are incompletely understood. We hypothesized that habitual soy food consumption associates with gut microbiome composition, metabolite production, and the interaction between diet, microbiota and metabolites. METHODS AND RESULTS: We analyzed dietary soy intake, plasma and stool metabolites, and gut microbiome data from two independent cross-sectional samples of healthy US individuals (N = 75 lean or overweight, and N = 29 obese). Habitual soy intake associated with several circulating metabolites. There was a significant interaction between soy intake and gut microbiome composition, as defined by gut enterotype, on metabolites in plasma and stool. Soy consumption associated with reduced systolic blood pressure, but only in a subset of individuals defined by their gut microbiome enterotype, suggesting that responsiveness to soy may be dependent on microbiome composition. Soy intake was associated with differences in specific microbial taxa, including two taxa mapping to genus Dialister and Prevotella which appeared to be suppressed by high soy intake We identified context-dependent effects of these taxa, where presence of Prevotella was associated with higher blood pressure and a worse cardiometabolic profile, but only in the absence of Dialister. CONCLUSIONS: The gut microbiome is an important intermediate in the interplay between dietary soy intake and systemic metabolism. Consumption of soy foods may shape the microbiome by suppressing specific taxa, and may protect against hypertension only in individuals with soy-responsive microbiota. CLINICAL TRIALS REGISTRY: NCT02010359 at clinicaltrials.gov.
Authors: Qiujun Yu; Yi-Yin Tai; Ying Tang; Jingsi Zhao; Vinny Negi; Miranda K Culley; Jyotsna Pilli; Wei Sun; Karin Brugger; Johannes Mayr; Rajeev Saggar; Rajan Saggar; W Dean Wallace; David J Ross; Aaron B Waxman; Stacy G Wendell; Steven J Mullett; John Sembrat; Mauricio Rojas; Omar F Khan; James E Dahlman; Masataka Sugahara; Nobuyuki Kagiyama; Taijyu Satoh; Manling Zhang; Ning Feng; John Gorcsan; Sara O Vargas; Kathleen J Haley; Rahul Kumar; Brian B Graham; Robert Langer; Daniel G Anderson; Bing Wang; Sruti Shiva; Thomas Bertero; Stephen Y Chan Journal: Circulation Date: 2019-05-07 Impact factor: 29.690
Authors: J Gregory Caporaso; Christian L Lauber; William A Walters; Donna Berg-Lyons; James Huntley; Noah Fierer; Sarah M Owens; Jason Betley; Louise Fraser; Markus Bauer; Niall Gormley; Jack A Gilbert; Geoff Smith; Rob Knight Journal: ISME J Date: 2012-03-08 Impact factor: 10.302
Authors: Marie Favennec; Benjamin Hennart; Marie Verbanck; Marie Pigeyre; Robert Caiazzo; Violeta Raverdy; Hélène Verkindt; Audrey Leloire; Gilles J Guillemin; Loïc Yengo; Delphine Allorge; Philippe Froguel; François Pattou; Odile Poulain-Godefroy Journal: PLoS One Date: 2016-06-21 Impact factor: 3.240
Authors: Tzu-Wen L Cross; Terese M Zidon; Rebecca J Welly; Young-Min Park; Steven L Britton; Lauren G Koch; George E Rottinghaus; Maria R Cattai de Godoy; Jaume Padilla; Kelly S Swanson; Victoria J Vieira-Potter Journal: Sci Rep Date: 2017-08-23 Impact factor: 4.379
Authors: Jane F Ferguson; Hooman Allayee; Robert E Gerszten; Folami Ideraabdullah; Penny M Kris-Etherton; José M Ordovás; Eric B Rimm; Thomas J Wang; Brian J Bennett Journal: Circ Cardiovasc Genet Date: 2016-04-19